| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 127 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 127 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 127 |
| 3 | METHOTREXATE SODIUM | 120 |
| 4 | METHOTREXATE | 98 |
| 5 | PREDNISONE | 98 |
| 6 | CARBOPLATIN | 96 |
| 7 | DEXAMETHASONE | 91 |
| 8 | DEXAMETHASONE 1.5 MG | 91 |
| 9 | CISPLATIN | 86 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATAZANAVIR AND COBICISTAT | 3 | 0.0122 |
| 1 | DINUTUXIMAB | 6 | 0.0070 |
| 2 | ZIV-AFLIBERCEPT | 6 | 0.0046 |
| 3 | SODIUM HYPOCHLORITE | 1 | 0.0038 |
| 4 | DIMETICONE | 1 | 0.0035 |
| 5 | PROBENECID | 4 | 0.0034 |
| 6 | PYRIMETHAMINE | 4 | 0.0031 |
| 7 | FOSCARNET SODIUM | 12 | 0.0030 |
| 8 | GRANULOCYTE COLONY STIMULATING FACTOR | 6 | 0.0028 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 23 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 234 |
| 1 | Platinum-based Drug [EPC] | 216 |
| 2 | Alkylating Drug [EPC] | 185 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 133 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 112 |
| 5 | Topoisomerase Inhibitor [EPC] | 84 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 79 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 61 |
| 8 | Kinase Inhibitor [EPC] | 60 |
| 9 | Microtubule Inhibitor [EPC] | 60 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 6 | 0.0055 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 4 | 0.0031 |
| 2 | Macrolide Antibacterial [EPC] | 3 | 0.0030 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 32 | 0.0014 |
| 4 | Actinomycin [EPC] | 3 | 0.0014 |
| 5 | Topoisomerase Inhibitor [EPC] | 84 | 0.0011 |
| 6 | Sulfonamide Antibacterial [EPC] | 4 | 0.0010 |
| 7 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 40 | 0.0008 |
| 9 | Platinum-based Drug [EPC] | 216 | 0.0008 |